GENEVA, July 2 -- NATERA, INC. filed a patent application (US2025/059382) for “METHODS FOR ASSESSMENT AND TREATMENT OF RELAPSE OF ANTIBODY-MEDIATED ALLOGRAFT REJECTION”. With publication no. WO/2026/136158, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6883
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....